Clinical Trial Update: Analysis of Circulating Tumor Markers in Blood - ALCINA 5 [NA]

View source ↗

Summary

A notice about the ALCINA 5 study examining circulating tumor markers in blood for non-small cell lung cancer; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Cancer, Lung Cancer, Non-Small Cell | NA | Status: NOT_YET_RECRUITING